PLEASANTON, Calif.--(BUSINESS WIRE)--10x Genomics today announced that Deanna Church, Ph.D. has joined the company as Senior Director of Applications. Dr. Church will be utilizing 10x’s powerful Linked-Read data to tackle the hard problems in biology, developing methods to unlock critical molecular and cellular information that to date has been out of reach.
“We are so excited to have Dr. Church on the team. She is one of the world’s leading experts in completing critical gaps in reference genomes. Her expertise will help us unlock full access to the human genome, enabling new discoveries in biology and medicine,” said Serge Saxonov, CEO of 10x Genomics.
Dr. Church comes to 10x Genomics from Personalis, where she was Senior Director of Genomics and Content. In that role, she developed bioinformatics tools and approaches to significantly improve genome analysis. Prior to that, she worked for the National Center for Biotechnology (NCBI) for 14 years. While there, she headed the Genome Reference Consortium team and led the effort to build truly high quality, maximally informative reference genomes.
"The 10x Linked-Read data allows us to think of new ways of doing genome analysis and will open the doors to parts of the genome that are challenging or impossible with current technologies. The chance to work on changing the way we do genome analysis was too compelling to pass up. I also found the new single-cell applications compelling and look forward to moving into this area,” said Dr. Church.
About 10x Genomics
10x Genomics meets the critical need for
long range, structural and cellular information, with an innovative
system that transforms the capability of existing short-read sequencers.
Our Chromium™ System supports comprehensive genomics and high-throughput
single cell transcriptomics. It enables researchers to discover
previously inaccessible genomic information at unprecedented scale,
including phased structural variants, phased single nucleotide variants,
and dynamic gene expression of individual cells—while leveraging their
existing sequencing systems and workflows.
